Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-075197

Director bought 409,090 shares at $11.00 ($4,499,990)

  • Director acquired 1,880,390 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mehra Anand Director 2015-10-13 Conversion +1,880,390 1,880,390 I: show line 1 in the form
Mehra Anand Director 2015-10-13 Purchase +409,090 $11.00 $4,499,990 2,289,480 I: show line 2 in the form
Open-market purchases · 409,090 sh · avg $11.00 · $4,499,990

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mehra Anand Director 2015-10-13 Conversion · Series A Preferred Stock −2,000,000 0 I: show line 3 in the form
Mehra Anand Director 2015-10-13 Conversion · Series B Preferred Stock −2,424,242 0 I: show line 4 in the form
Mehra Anand Director 2015-10-13 Conversion · Series C Preferred Stock −2,063,107 0 I: show line 5 in the form
Loading xslF345X03/doc4.xml…